Latest filing published 10 Sept 2026 for StepStone Group Inc., €245k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David F. Hoffmeister (board member) discloses dealings in 5 companies, chiefly Invitrogen Corp, Celanese Corp and GLAUKOS Corp. Between 15 May 2007 and 8 September 2026, the trades on record add up to 118 filings.
Market trades split into 1 purchase (€920k) and 22 sales (€8.6M). Taken together, the sales exceed the purchases by €7.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 66 share grants and 27 option exercises.
On 10 September 2026 came the latest disclosure, a share grant for €245k in StepStone Group Inc. The last insider purchase was made public on 31 May 2024, 876 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations